BRD4 inhibitors (CRELUX/4SC Discovery)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBRD4 inhibitors (CRELUX/4SC Discovery)
Drug Alias Namebromodomain containing protein 4 inhibitors (CRELUX/4SC Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 degraders
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCRELUX Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCRELUX Gmbh4SC Discovery Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A